Echinocandins: Ask not what they can do for esophageal candidiasis - Ask what studies of esophageal candidiasis can do for them

被引：4

作者：

Darouiche, RO

机构：

[1] Baylor Coll Med, Ctr Protheses Infect, Houston, TX 77030 USA

[2] Michael E Debakey Vet Affairs Med Ctr, Infect Dis Sect, Houston, TX USA

[3] Michael E Debakey Vet Affairs Med Ctr, Ctr Protheses Infect, Houston, TX USA

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷 / 06期

关键词：

D O I：

10.1086/423391

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：850 / 852

页数：3

共 17 条

[1] A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients [J].

Ally, R ;

Schürmann, D ;

Kreisel, W ;

Carosi, G ;

Aguirrebengoa, K ;

Dupont, B ;

Hodges, M ;

Troke, P ;

Romero, AJ .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) :1447-1454

[2] Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature [J].

Anaissie, EJ ;

Darouiche, RO ;

AbiSaid, D ;

Uzun, O ;

Mera, J ;

Gentry, LO ;

Williams, T ;

Kontoyiannis, DP ;

Karl, CL ;

Bodey, GP .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :964-972

[3] Randomized, double-blind, Multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases [J].

Arathoon, EG ;

Gotuzzo, E ;

Noriega, LM ;

Berman, RS ;

DiNubile, MJ ;

Sable, CA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :451-457

[4] In vitro activity of caspofungin against Candida albicans biofilms [J].

Bachmann, SP ;

VandeWalle, K ;

Ramage, G ;

Patterson, TF ;

Wickes, BL ;

Graybill, JR ;

López-Ribot, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3591-3596

[5] Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues [J].

Darouiche, RO .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :259-272

[6] A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients [J].

de Wet, N ;

Llanos-Cuentas, A ;

Suleiman, J ;

Baraldi, E ;

Krantz, EF ;

Della Negra, M ;

Diekmann-Berndt, H .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :842-849

[7] Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal [J].

Dowell, JA ;

Knebel, W ;

Ludden, T ;

Stogniew, M ;

Krause, D ;

Henkel, T .

JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (06) :590-598

[8] Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole [J].

Kartsonis, N ;

DiNubile, MJ ;

Bartizal, K ;

Hicks, PS ;

Ryan, D ;

Sable, CA .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) :183-187

[9] Candida infections of medical devices [J].

Kojic, EM ;

Darouiche, RO .

CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (02) :255-+

[10] A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis [J].

Krause, DS ;

Simjee, AE ;

van Rensburg, C ;

Viljoen, J ;

Walsh, TJ ;

Goldstein, BP ;

Wible, M ;

Henkel, T .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :770-775

← 1 2 →